Merck KGaA

Research Merck KGaA (MRK.DE) on Bullrun: market cap EUR 59.52B, P/E 25.1, dividend yield 1.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 59.52B; P/E is 25.1; dividend yield is 1.6%.

Peer valuation comparison

Latest P/E is 25.12x versus a Healthcare sector median of 24.6x (2.1% above).

Latest dividend yield is 1.6% versus a Healthcare sector median of 1.84% (13.0% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 21.10BEUR 2.61BEUR 1.98B58.5%n/aEUR 2.33BEUR 11.95BEUR 28.59B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-04EUR 59.52B25.11.6%2.2

Dividend history

Latest trailing dividend snapshot: annual dividend/share 2.2 EUR, yield 1.6%.

About Merck KGaA

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector;

ETFs that hold Merck KGaA

Merck KGaA is one of the ten largest holdings of 4 ETFs that investors in Europe can buy, most traded first:

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Merck KGaA's market cap?

Merck KGaA's market capitalization is EUR 59.52B.

What is Merck KGaA's P/E ratio?

Merck KGaA's price-to-earnings (P/E) ratio is 25.1.

Does Merck KGaA pay a dividend?

Merck KGaA has a dividend yield of 1.6%.

What does Merck KGaA do?

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments.